SCHEMBL12411518

SCHEMBL12411518

[C-]#[N+]c1cc2c(Oc3ccc(NC(=O)Nc4ccc(F)cc4)cc3)ccnc2cc1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 16/20 0.67
KDR P35968 15/20 0.67
MET P08581 4/20 0.57
AURKA O14965 1/20 0.53
RIPK2 O43353 1/20 0.53
ABCB11 O95342 1/20 0.53
ABL1 P00519 1/20 0.53
EGFR P00533 1/20 0.53
ERBB2 P04626 1/20 0.53
NTRK1 P04629 1/20 0.53
LCK P06239 1/20 0.53
PGR P06401 1/20 0.53
LYN P07948 1/20 0.53
RET P07949 1/20 0.53
CHRM2 P08172 1/20 0.53
HCK P08631 1/20 0.53
ADRA2A P08913 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
KIT P10721 1/20 0.53
CHRM1 P11229 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12410882 0.92 KDR (0.63) PDGFRAKDRMETKITFLT1
SCHEMBL12411563 0.91 PDGFRA (0.66) PDGFRAKDRMETKIT
SCHEMBL12411520 0.90 PDGFRA (0.70) PDGFRAKDR
SCHEMBL12411377 0.88 PDGFRA (0.80) PDGFRAKDRMETAURKARIPK2
SCHEMBL12412233 0.86 PDGFRA (0.80) PDGFRAKDRMETAURKARIPK2
SCHEMBL12411510 0.86 PDGFRA (0.52) PDGFRAKDRAXL
SCHEMBL12411579 0.85 PDGFRA (0.63) PDGFRAKDRMETAURKARIPK2
SCHEMBL12411522 0.85 PDGFRA (0.63) PDGFRAKDRMETAURKARIPK2
SCHEMBL12411524 0.85 KDR (0.69) PDGFRAKDRMETKITFLT1
SCHEMBL12411329 0.84 PDGFRA (0.67) PDGFRAKDRMETAURKARIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 PDGFRA 3131/4885KDR 2687/4885MET 1810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.